Abstract In the current era, 5%-10% of Fontan patients die or need a transplant in childhood,
and approximately 50% will experience the same fate by age 40 years. Heart transplant …

With increasing knowledge of immunologic factors and with the advent of potent
immunosuppressive agents, the last several decades have seen significantly improved …

Background Anti-human leukocyte antigen (HLA) antibody testing was approved by the
Japanese government in 2018. As such, there was no longitudinal data regarding the HLA …

The first human corneal transplantation was performed in 1905 by Eduard Zirm in the
Olomouc Eye Clinic, now Czech Republic. However, despite great advancements in …

Calculated panel reactive antibody (CPRA) is used to help increase sensitized patient's
access to transplantation. United Arab Emirates (UAE) has a diverse resident population …

Over 150,000 organ transplants are performed annually worldwide, and transfusion
medicine support is crucial for each patient. Liver transplants have posed the greatest …

The effects of HLA mismatching on pancreas outcomes among pancreas after kidney (PAK)
recipients are undefined. Outcomes might potentially differ depending on whether there is a …

Background Pronase pretreatment can reduce rituximab (RTX) interference by degrading
CD20 in B-cell flow cytometry crossmatch (FCXM) testing. However, it may also reduce the …

The relevance of pre-existing HLA-antibodies (HLA-Ab) in liver transplantation (LTx) is
controversial. While livers are allocated without HLA match or preoperative crossmatch …

Background and Objectives: Testing for anti-human leukocyte antigen (HLA) antibodies both
before and after transplantation is of fundamental significance for the success of lung …